Chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for Mycobacterium tuberculosis.
J Biomater Appl
; 37(1): 40-47, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35430919
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Tuberculosis
/
Chitosan
/
Nanoparticles
/
Mycobacterium tuberculosis
Limits:
Animals
Language:
En
Year:
2022
Type:
Article